Artiva Biotherapeutics, Inc. · NASDAQ:ARTV
Aslan Fred received 45,000 Artiva Biotherapeutics, Inc. shares as an award (Form 4)
Traded Sep 10, 2026 · Filed Sep 14, 2026
On Sep 10, 2026, Aslan Fred (Director, Chief Executive Officer) received 45,000 Artiva Biotherapeutics, Inc. shares as an award, leaving 1,494,765 shares. Filed Sep 14, 2026 (Form 4).
- Awarded
- 45,000 shares
- Holding after
- 1,494,765 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Common Stock | Award | 45,000 | 1,494,765 | Direct |
Source
Related
- Artiva Biotherapeutics, Inc.
- Aslan Fred
- Artiva Biotherapeutics, Inc. shareholders
- Form 4 · Aslan Fred · Nov 18, 2026
- Form 4 · Aslan Fred · Nov 3, 2026
- Form 4 · Aslan Fred · Oct 7, 2026
- Form 4 · Aslan Fred · Oct 6, 2026
- Form 4 · Aslan Fred · Sep 15, 2026
- Form 4 · Miralles Gines Diego · Nov 18, 2026
- Form 4 · Horan Christopher · Nov 18, 2026
- Form 4 · Bush Jennifer · Nov 18, 2026
- Form 4 · Banerjee Subhashis · Nov 18, 2026
- Form 4 · Horan Christopher · Nov 3, 2026